January 28, 2015 12:10 PM ET

Pharmaceuticals

Company Overview of Mankind Pharma Limited

Company Overview

Mankind Pharma Limited manufactures pharmaceutical products. It offers products in the areas of antibiotics, antifungals, gastrointestinals, anthelmintics, cardiovascular products, dermal products, ophthalmic, antibacterial, acute and chronic disease, antipsychotic, veterinary, antidiabetic, hypothyroidism, cough prepration, antimalarial, antimigraine, anti-viral, steriods, opthalmic, gynaecological, and anti-asthmatics. The company also provides consumer products, such as emergency contraceptives, pregnancy detection cards, antacids, condoms, sanitary napkins, body sprays, pregnancy test kits, toothbrushes, and sweeteners. It sells its products through a network of stockists and C&F agents....

236, Okhla

Phase-III

New Delhi,  110 020

India

Founded in 1991

Phone:

91 11 4654 1400

Fax:

91 11 4654 1382

Key Executives for Mankind Pharma Limited

Chairman
Age: 59
Whole Time Director
Age: 67
Whole Time Director
Age: 23
Director of Marketing and Director
Director of Marketing and Director
Compensation as of Fiscal Year 2014.

Mankind Pharma Limited Key Developments

Mankind Pharma Mulls Acquisitions

Mankind Pharma Limited is looking for potential acquisitions or mergers, and growth opportunities abroad.

Warburg Pincus May Buy ChrysCap's Stake In Mankind Pharma

Warburg Pincus LLC is planning to acquire the 11% stake held by ChrysCapital in Mankind Pharma Limited for about $250 million, apart from making a primary infusion. If the deal goes through, ChrysCap would make a 9x returns on its seven year old investment.

ChrysCapital Reportedly In Talks To Sell Mankind Pharma

ChrysCapital intends to sell its stake in Mankind Pharma Limited. ChrysCapital is holding talks to sell its 11% stake in Mankind Pharma. The potential buyers are all PE firms, including Temasek Holdings (Private) Limited, General Atlantic LLC, Actis Capital, LLP and Advent International Corporation. ChrysCapital hopes to fetch over $200 million for its 11% holding. Financial Services Monitor Worldwide added that Ramesh Juneja, Chief Executive Officer of Mankind, said in an email response: Regarding ChrysCapital seeking exit from Mankind you may directly speak with them because it is entirely their decision. ChrysCapital spokesperson Sanjiv Kaul declined comment.

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 21, 2014
Casablanca Industries Private Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mankind Pharma Limited, please visit www.mankindpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.